参考文献: [1] Ni WJ, Yeo YH, Rui FJ, et al. Validation Of The PAP Model Performance For Diagnosing Advanced Fibrosis And Cirrhosis In Chronic Hepatitis B Patients With Concurrent Hepatic Steatosis Across Different Subgroups [J]. AASLD2023, Abstracts (1332-C). [2] Xu XM, Rui FJ, Ni WJ...
3.Liu M, Tseng TC, Jun DW, et al. Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients. Hepatol Int. 2021;15(1):71-81.4.Park J, Le AK, Tseng TC, et al. Progression Rates by Age, Sex, Treatment, and...
甲磺酸帕拉德福韦片与富马酸替诺福韦二吡呋酯片平行对照治疗慢性乙型肝炎的有效性和安全性:多中心、随机、双盲、Ⅲ期临床研究 1452-C | A RANDOMISED, DOUBLE-BLIND, PHASE 3, NONINFERIORITY TRIAL OF PRADEFOVIR MESYLATE VERSUS TENO...
甲磺酸帕拉德福韦片与富马酸替诺福韦二吡呋酯片平行对照治疗慢性乙型肝炎的有效性和安全性:多中心、随机、双盲、Ⅲ期临床研究 1452-C | A RANDOMISED, DOUBLE-BLIND, PHASE 3, NONINFERIORITY TRIAL OF PRADEFOVIR MESYLATE VERSUS TENOFOVIR DISOPROXIL FUMARATE FOR PAITENTS WITH CHRONIC HEPATITIS B VIRUS INFECTIO...
Ding WM, Wang J, Huang R, Xue Q, Wang XQ, Qi XL, Shi JP, Wu C, Liang J, Li J. Validation of the PAP model performance for diagnosing advanced fibrosis and cirrhosis in chronic hepatitis B patients with concurrent hepatic steatosis across different subgroups. AASLD2023, Abstract (1332-C...
富马酸丙酚替诺福韦(Tenofovir alafenamide,TAF)是各大指南推荐治疗慢性乙型肝炎chronic hepatitis B,CHB)的一线抗病毒治疗药物。3期随机对照研究显示TAF不劣于富马酸替诺福韦二吡呋酯(tenofovir disoproxil fumarate,TDF)的抗病毒疗效,且...
Stable recompensation in entecavir-treated hepatitis B Patients with decompensated cirrhosis. AASLD 2023. Poster 1440-C. [2] Deng Y, Zhang S, Chen W, et al. Efficacy and safety of tenofovir alafenamide in the treatment of decompensated cirrhotic patients with chronic hepatitis B. AASLD 2023. ...
Ding WM, Wang J, Huang R, Xue Q, Wang XQ, Qi XL, Shi JP, Wu C, Liang J, Li J. Validation of the PAP model performance for diagnosing advanced fibrosis and cirrhosis in chronic hepatitis B patients with concurrent hepatic steatosis across different subgroups. AASLD2023, Abstract (1332-C...
富马酸丙酚替诺福韦(Tenofovir alafenamide,TAF)是各大指南推荐治疗慢性乙型肝炎chronic hepatitis B,CHB)的一线抗病毒治疗药物。3期随机对照研究显示TAF不劣于富马酸替诺福韦二吡呋酯(tenofovir disoproxil fumarate,TDF)的抗病毒疗效,且具有更好的肾脏和骨骼安全性。但目前对于TAF长期治疗中国初治和经治CHB患者的疗...
1527-C | MECHANISM RESEARCH ON THE INTERACTION BETWEEN HEPATITIS B VIRUS X PROTEIN AND LINE-1 通讯作者:高普均、赵可第一作者:赵旭 研究背景及目的 I型长弥散核元件(LINE-1),是人体细胞中唯一已知具有自主转座活性的逆转录元件,在基因组进化、基因组稳定性以及宿主天然免疫反应中均具有重要生物学意义。